306 related articles for article (PubMed ID: 8353949)
21. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders.
Martinez M
Brain Res; 1992 Jun; 583(1-2):171-82. PubMed ID: 1504825
[TBL] [Abstract][Full Text] [Related]
22. Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
Scott AI
Methods Mol Biol; 2022; 2546():501-508. PubMed ID: 36127617
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of branched chain fatty acids in peroxisomal disorders.
Singh H; Usher S; Johnson D; Poulos A
J Inherit Metab Dis; 1990; 13(3):387-9. PubMed ID: 1700192
[No Abstract] [Full Text] [Related]
24. Biochemical and clinical profiles of 52 Tunisian patients affected by Zellweger syndrome.
Nasrallah F; Zidi W; Feki M; Kacem S; Tebib N; Kaabachi N
Pediatr Neonatol; 2017 Dec; 58(6):484-489. PubMed ID: 28330580
[TBL] [Abstract][Full Text] [Related]
25. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
27. Fatty alcohol accumulation in the autosomal recessive form of rhizomelic chondrodysplasia punctata.
Rizzo WB; Craft DA; Judd LL; Moser HW; Moser AB
Biochem Med Metab Biol; 1993 Aug; 50(1):93-102. PubMed ID: 8373640
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin.
Malle E; Oettl K; Sattler W; Hoefler G; Kostner GM
Eur J Clin Invest; 1995 Jan; 25(1):59-67. PubMed ID: 7705389
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of straight chain and branched chain fatty acid oxidation in skin fibroblasts from patients with peroxisomal disorders.
Singh H; Usher S; Johnson D; Poulos A
J Lipid Res; 1990 Feb; 31(2):217-25. PubMed ID: 1691260
[TBL] [Abstract][Full Text] [Related]
30. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
[TBL] [Abstract][Full Text] [Related]
31. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
[TBL] [Abstract][Full Text] [Related]
32. Arachidonic acid metabolism in fibroblasts from patients with peroxisomal diseases: response to interleukin 1.
Tiffany CW; Hoefler S; Moser HW; Burch RM
Biochim Biophys Acta; 1990 Nov; 1096(1):41-6. PubMed ID: 2125233
[TBL] [Abstract][Full Text] [Related]
33. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy.
Ofman R; Dijkstra IM; van Roermund CW; Burger N; Turkenburg M; van Cruchten A; van Engen CE; Wanders RJ; Kemp S
EMBO Mol Med; 2010 Mar; 2(3):90-7. PubMed ID: 20166112
[TBL] [Abstract][Full Text] [Related]
34. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
[TBL] [Abstract][Full Text] [Related]
35. Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy.
Rattay TW; Rautenberg M; Söhn AS; Hengel H; Traschütz A; Röben B; Hayer SN; Schüle R; Wiethoff S; Zeltner L; Haack TB; Cegan A; Schöls L; Schleicher E; Peter A
Sci Rep; 2020 Sep; 10(1):15093. PubMed ID: 32934269
[TBL] [Abstract][Full Text] [Related]
36. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
[TBL] [Abstract][Full Text] [Related]
37. Peroxisomal beta-oxidation of polyunsaturated long chain fatty acids in human fibroblasts. The polyunsaturated and the saturated long chain fatty acids are retroconverted by the same acyl-CoA oxidase.
Christensen E; Woldseth B; Hagve TA; Poll-The BT; Wanders RJ; Sprecher H; Stokke O; Christophersen BO
Scand J Clin Lab Invest Suppl; 1993; 215():61-74. PubMed ID: 8327852
[TBL] [Abstract][Full Text] [Related]
38. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
39. Adrenoleukodystrophy: a correlation between saturated very long-chain fatty acids in mononuclear cells and phenotype.
Antoku Y; Koike F; Ohtsuka Y; Sakai T; Tsukamoto K; Nagara H; Iwashita H; Goto I
Ann Neurol; 1991 Jul; 30(1):101-3. PubMed ID: 1929220
[TBL] [Abstract][Full Text] [Related]
40. Plasma bile acids in patients with peroxisomal dysfunction syndromes: analysis by capillary gas chromatography-mass spectrometry.
Clayton PT; Lake BD; Hall NA; Shortland DB; Carruthers RA; Lawson AM
Eur J Pediatr; 1987 Mar; 146(2):166-73. PubMed ID: 2436918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
